The impacts of SARS-CoV-2 vaccine dose separation and targeting on the COVID-19 epidemic in England. (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-023-35943-0

PubMed Identifier: 36765050

Publication URI: http://europepmc.org/abstract/MED/36765050

Type: Journal Article/Review

Volume: 14

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723